African Pharma's Fragmentation Premium Is Shrinking. Here's What Investors Need to Watch
Africa’s pharmaceutical market, long slowed by years of regulatory processes, is undergoing a sharp cut that could create faster access to multiple African markets. The shift hints at a transformation that may reshape pan‑African pharmaceutical opportunities.